These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2164113)

  • 21. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
    Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A
    J BUON; 2007; 12(2):245-52. PubMed ID: 17600880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
    Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antiemetic efficacy of high-dose metoclopramide, diphenhydramine, methylprednisolone and diazepam on chemotherapy-induced emesis in gynecological malignancy].
    Hayashi Y; Iwasaka T; Hachisuga T; Fukuda K; Tanaka T; Matsuo N; Sugimori H
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul; 40(7):875-9. PubMed ID: 3418195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
    Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M
    Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
    Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis].
    Ariyoshi Y; Nukariya N; Akasaka Y; Suminaga M; Ota J; Ikeda M; Taguchi T
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):995-1011. PubMed ID: 9212810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multi-drug antiemetic treatment and effect of treatment duration of concurrent steroids--for complete control of chemotherapy-induced nausea/vomiting in gynecological cancer].
    Fujii T; Nakata N; Shiroyama Y; Sawasaki T; Tanimoto H; Shigemasa K; Kioka H; Naito H
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2245-52. PubMed ID: 9422069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pilot combination phase II study of mitomycin C plus cisplatin for non-small cell lung cancer].
    Shimizu E; Kamei T; Kimura K; Mukai J; Nakamura Y; Kunishige E; Fukuta K; Tani K; Sone S; Ogura T
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3719-23. PubMed ID: 2556971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A comparative study of the effects of granisetron alone and a combination of granisetron plus steroids on CDDP-based combination chemotherapy-induced emesis--outcomes of a multicenter randomized comparative study using the central registration method. Nara Medical University Kytril Study Group].
    Ozono S; Okajima E; Hirao YK; Natsume O; Kaneko Y; Ohara S; Tabata S; Watanabe S; Aoyama H; Sasaki K; Matsuki H; Takashima K; Maruyama Y; Yoshikawa M; Yamada K; Momose H; Hiramatsu T; Hayashi Y; Babaya K; Shiomi T
    Gan To Kagaku Ryoho; 1997 Feb; 24(3):349-56. PubMed ID: 9051139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antiemetic treatment with metoclopramide and high-dose lorazepam and additional long-term treatment with lorazepam during CDDP administration].
    Ito T; Ibe Y; Naito S; Fujieda K; Okubo S; Morinari H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):673-6. PubMed ID: 3128182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of ramosetron and granisetron for the prevention of acute and delayed emesis in Cisplatin-based chemotherapy: a randomized controlled trial.
    Cheirsilpa A; Sinthusake T; Songsakkaesorn A; Visawaprasit S; Chulaka K; Changkuingdee N
    Jpn J Clin Oncol; 2005 Dec; 35(12):695-9. PubMed ID: 16319109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiemetic activity of high-dose methylprednisolone associated with continuous-infusion metoclopramide and oral alprazolam during multiple-day chemotherapy.
    Salles G; Archimbaud E; Thomas X; Fiere D
    Cancer Chemother Pharmacol; 1991; 28(1):77-9. PubMed ID: 2040038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
    Roila F; Tonato M; Basurto C; Picciafuoco M; Bracarda S; Donati D; Malacarne P; Monici L; Di Costanzo F; Patoia L
    J Clin Oncol; 1989 Nov; 7(11):1693-700. PubMed ID: 2681556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of intermittent versus continuous infusion metoclopramide in control of acute nausea induced by cisplatin chemotherapy.
    Navari RM
    J Clin Oncol; 1989 Jul; 7(7):943-6. PubMed ID: 2544688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiemetic efficacy of alprazolam in carboplatin-induced emesis.
    Tsavaris N; Tsoutsos H; Bacoyannis C; Mylonakis N; Karvounis N; Kozatsani-Halividi D; Tsaroucha-Noutsou E; Klinaki A; Kosmidis P
    Chemotherapy; 1991; 37(5):364-70. PubMed ID: 1804597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of continuous and intermittent bolus infusions of metoclopramide during 5-day continuous intravenous infusion with cisplatin.
    Mori K; Saitou Y; Tominaga K; Yokoi ; Miyazawa N
    Eur J Cancer; 1991; 27(6):729-32. PubMed ID: 1648944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between neurotransmitter blood noradrenalin and nausea/emesis after chemotherapy for lung cancer].
    Inoue S; Endo K; Endo K; Nakamura R; Itou H
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):931-6. PubMed ID: 16835482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of ondansentron (GR 38032F) versus ondansentron plus alprazolam as antiemetic prophylaxis during cisplatin-containing chemotherapy.
    Tsavaris N; Charalambidis G; Pagou M; Karabelis A; Mylonakis N; Bacoyiannis C; Kosmidis P
    Am J Clin Oncol; 1994 Dec; 17(6):516-21. PubMed ID: 7977173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.